מונטהלוקאסט אינובמד 10 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

MONTELUKAST AS SODIUM 10 MG

Mevcut itibaren:

INOVAMED LTD

ATC kodu:

R03DC03

Farmasötik formu:

FILM COATED TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

SYNTHON B.V., NETHERLANDS

Terapötik grubu:

MONTELUKAST

Terapötik endikasyonlar:

Montelukast Inovamed is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

Yetkilendirme tarihi:

2012-05-01